Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes

Código QR

Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes

Henri K Parson, Meredith A Bundy, Charlotte B Dublin, Amanda L Boyd, James F Paulson, Aaron I VinikLeonard R. Strelitz Diabetes Center, Department of Internal Medicine Eastern Virginia Medical School, Norfolk, Virginia, USAAbstract: Rosuvastatin is known to reduce low-density lipoprotein (LDL)-chole...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Parson H
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	neurovascular function rosuvastatin and diabetes Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/9cbf4e31e9d74840b13e6430fc1dd6b9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes
por: Henri K Parson, et al.
Publicado: (2010)

COMPARISON OF LIPID LOWERING EFFECTS OF ROSUVASTATIN AND ATORVASTATIN IN TYPE 2 DIABETIC PATIENTS WITH PRIMARY HYPERLIPIDEMIA
por: Safina Shabbir, et al.
Publicado: (2020)

Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study
por: Hernández-Ojeda J, et al.
Publicado: (2014)

Association Between Abnormal Glycemic Phenotypes and Microvascular Complications of Type 2 Diabetes Mellitus Outpatients in China
por: Liu G, et al.
Publicado: (2020)

Aerobic training increases skin perfusion by a nitric oxide mechanism in type 2 diabetes
por: Sheri R Colberg, et al.
Publicado: (2010)

Difference Analysis Of Related Factors In Macrovascular And Microvascular Complications In Chinese Patients With Type 2 Diabetes Mellitus: A Case-Control Study Protocol
por: Zhao H, et al.
Publicado: (2019)

Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation
por: Schuster D
Publicado: (2010)

LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA
por: ASHFAQ,MUHAMMAD, et al.
Publicado: (2013)

Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 Diabetes
por: Takahara M, et al.
Publicado: (2020)

Higher Serum Asprosin Level is Associated with Urinary Albumin Excretion and Renal Function in Type 2 Diabetes
por: Deng X, et al.
Publicado: (2020)

Saxagliptin for type 2 diabetes
por: Antonio R Chacra, et al.
Publicado: (2010)

Awareness of diabetic retinopathy among patients with type 2 diabetes mellitus in Jordan
por: Bakkar MM, et al.
Publicado: (2017)

Comparative effectiveness of liraglutide in the treatment of type 2 diabetes
por: Rigato M, et al.
Publicado: (2014)

Interactive Effect of IGF2BP2 rs4402960 Variant, Smoking and Type 2 Diabetes
por: Nfor ON, et al.
Publicado: (2020)

Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea
por: Kunavisarut T, et al.
Publicado: (2019)

Diabetes-Related Distress Among People with Type 2 Diabetes in Ho Chi Minh City, Vietnam: Prevalence and Associated Factors
por: Huynh G, et al.
Publicado: (2021)

Association between lipid accumulation product and diabetic retinopathy based on a community-based survey in Chinese with type 2 diabetes
por: Wu J, et al.
Publicado: (2019)

Altered Functional Connectivity Strength of Primary Visual Cortex in Subjects with Diabetic Retinopathy
por: Qi CX, et al.
Publicado: (2021)

Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus
por: Mazzilli R, et al.
Publicado: (2015)

Topiramate improves neurovascular function, epidermal nerve fiber morphology, and metabolism in patients with type 2 diabetes mellitus
por: Boyd A
Publicado: (2010)

Type 2 diabetes in Brazil: epidemiology and management
por: Almeida-Pititto B, et al.
Publicado: (2015)

Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation
por: Dara P Schuster
Publicado: (2010)

Incidence of Diabetic Retinopathy and Its Predictors Among Newly Diagnosed Type 1 and Type 2 Diabetic Patients: A Retrospective Follow-up Study at Tertiary Health-care Setting of Ethiopia
por: Debele GR, et al.
Publicado: (2021)

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
por: Omoto S, et al.
Publicado: (2015)

The Effects of Type 2 Diabetes and Postoperative Pneumonia on the Mortality in Inpatients with Surgery
por: Ma C, et al.
Publicado: (2019)

Prevalence and identification of type 1 diabetes in Chinese adults with newly diagnosed diabetes
por: Tang X, et al.
Publicado: (2019)

Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
por: Saunders WB, et al.
Publicado: (2016)

Interhemispheric Functional Connectivity Alterations in Diabetic Optic Neuropathy: A Resting-State Functional Magnetic Resonance Imaging Study
por: Tan SW, et al.
Publicado: (2021)

Assessing the effect of weight and weight loss in obese persons with type 2 diabetes
por: Bradley Curtis, et al.
Publicado: (2008)

Predictors of major lower limb amputation in type 2 diabetic patients referred for hospital care with diabetic foot syndrome
por: Shatnawi NJ, et al.
Publicado: (2018)

Linking obesity with type 2 diabetes: the role of T-bet
por: Wali JA, et al.
Publicado: (2014)

Risk management in the treatment of type 2 diabetes with pioglitazone
por: Giuseppe Derosa, et al.
Publicado: (2009)

Depression in people with type 2 diabetes: current perspectives
por: Darwish L, et al.
Publicado: (2018)

Incidence of Cardiovascular Complications and Nephropathy in Patients with Type 2 Diabetes in a Primary Care Setting in Riyadh, Saudi Arabia
por: Alsaidan M, et al.
Publicado: (2021)

The association of weight loss with patient experience and outcomes in a population of patients with type 2 diabetes mellitus prescribed canagliflozin
por: Gerlanc NM, et al.
Publicado: (2017)

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review
por: Gregory E Peterson
Publicado: (2009)

Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus
por: Pamela Kushner
Publicado: (2010)

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
por: Joshua J Neumiller, et al.
Publicado: (2010)

Evidence for the benefit of exercise therapy in patients with type 2 diabetes
por: Madden KM
Publicado: (2013)

Insulin detemir for the treatment of obese patients with type 2 diabetes
por: Hollander PA
Publicado: (2012)